Business Description
PolyPeptide Group AG
ISIN : CH1110760852
Total Employee Number:
1,395Compare
Compare
Traded in other countries / regions
PPGN.Switzerland0AAJ.UK8H0.GermanyPLYGF.USA IPO Date
2025-05-02Description
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 4.6 | |||||
Interest Coverage | 0.83 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.86 | |||||
Beneish M-Score | -3.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.3 | |||||
3-Year EBITDA Growth Rate | -9.1 | |||||
3-Year FCF Growth Rate | 26 | |||||
3-Year Book Growth Rate | -8.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.79 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.17 | |||||
9-Day RSI | 51.96 | |||||
14-Day RSI | 56.29 | |||||
3-1 Month Momentum % | 3.93 | |||||
6-1 Month Momentum % | 14.2 | |||||
12-1 Month Momentum % | 65.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 0.91 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 171.3 | |||||
Days Sales Outstanding | 61.42 | |||||
Days Payable | 80.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.88 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.96 | |||||
Operating Margin % | 2.2 | |||||
Net Margin % | -5.43 | |||||
EBITDA Margin % | 7.22 | |||||
FCF Margin % | -8.01 | |||||
OCF Margin % | 19.78 | |||||
ROE % | -6.2 | |||||
ROA % | -2.71 | |||||
ROIC % | 1.36 | |||||
3-Year ROIIC % | -3.14 | |||||
ROC (Joel Greenblatt) % | -2 | |||||
ROCE % | -1.65 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 68.06 | |||||
Price-to-Owner-Earnings | 215.96 | |||||
PS Ratio | 4.14 | |||||
PB Ratio | 4.78 | |||||
Price-to-Tangible-Book | 4.77 | |||||
Price-to-Operating-Cash-Flow | 20.97 | |||||
EV-to-EBIT | -170.68 | |||||
EV-to-Forward-EBIT | 36.01 | |||||
EV-to-EBITDA | 58.94 | |||||
EV-to-Revenue | 4.25 | |||||
EV-to-Forward-Revenue | 3.43 | |||||
EV-to-FCF | -53.59 | |||||
Price-to-GF-Value | 1.42 | |||||
Price-to-Projected-FCF | 11.83 | |||||
Earnings Yield (Greenblatt) % | -0.58 | |||||
FCF Yield % | -1.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PolyPeptide Group AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 391.871 | ||
| EPS (TTM) (€) | -0.64 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 48.49 | ||
| 14-Day RSI | 56.29 | ||
| 14-Day ATR (€) | 1.446203 | ||
| 20-Day SMA (€) | 46.505 | ||
| 12-1 Month Momentum % | 65.18 | ||
| 52-Week Range (€) | 21.4 - 53 | ||
| Shares Outstanding (Mil) | 33.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PolyPeptide Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PolyPeptide Group AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
PolyPeptide Group AG Frequently Asked Questions
What is PolyPeptide Group AG(FRA:8H0)'s stock price today?
The current price of FRA:8H0 is €48.40. The 52 week high of FRA:8H0 is €53.00 and 52 week low is €21.40.
When is next earnings date of PolyPeptide Group AG(FRA:8H0)?
The next earnings date of PolyPeptide Group AG(FRA:8H0) is .
Does PolyPeptide Group AG(FRA:8H0) pay dividends? If so, how much?
PolyPeptide Group AG(FRA:8H0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PolyPeptide Group AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers